About Vaxiion Therapeutics

About company

​​​​​​​Vaxiion Therapeutics is a clinical stage biopharmaceutical company developing a proprietary biopharmaceutical drug delivery system based on its targeted recombinant bacterial minicell (rBMC) technology for use in cancer. rBMCs are small, chromosomeless (i.e., non-living and non-infectious), spherical bacterial particles engineered to encapsulate, target, and deliver a wide array of therapeutically relevant molecules (including protein toxins, small molecule drugs, RNAi, plasmids, peptides, and imaging agents) directly to cancer cells.